| Literature DB >> 30344257 |
Hammad M A Aliahmed1, Rimantas Karalius2, Arūnas Valaika3, Arimantas Grebelis4, Palmyra Semėnienė5, Rasa Čypienė6.
Abstract
Background: new minimally invasive sternotomy (mini-sternotomy) procedures have improved the treatment outcome and reduced the incidence of perioperative complications leading to improved patient satisfaction and a reduced cost of aortic valve replacement in comparison to the conventional median sternotomy (full sternotomy). The aim of this study is to compare and gain new insights into operative and early postoperative outcomes, long-term postoperative results, and 5-year survival rates after aortic valve replacement through a ministernotomy and full sternotomy.Entities:
Keywords: aortic valve replacement; ministernotomy; sternotomy
Mesh:
Year: 2018 PMID: 30344257 PMCID: PMC6037263 DOI: 10.3390/medicina54020026
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Preoperative patients’ characteristics.
| Indicator | Overall Cohort | Propensity Score Matched Cohort | ||||
|---|---|---|---|---|---|---|
| Mini-Sternotomy | Full Sternotomy |
| Mini-Sternotomy | Full Sternotomy |
| |
| Age, mean ± SD, years | 60.8 ± 11.6 | 63.3 ± 13.2 | 0.155 | 60.8 ± 11.6 | 61.4 ± 11.9 | 0.155 |
| Male, | 42 (60.0) | 193 (54.2) | 0.384 | 42 (60) | 42 (60) | 1.000 |
| Height, mean ± SD, cm | 170.8 ± 10.0 | 169.3 ± 10.2 | 0.247 | 170.8 ± 10.0 | 170.1 ± 9.0 | 0.247 |
| Body weight, mean ± SD, kg | 82.3 ± 1.8 | 82.6 ± 1.8 | 0.886 | 82.3 ± 1.8 | 81.0 ± 1.6 | 0.886 |
| BMI, mean ± SD, kg/m2 | 27.7 ± 4.4 | 28.8 ± 5.6 | 0.656 | 27.7 ± 4.4 | 27.9 ± 4.5 | 0.536 |
| Diagnosis, | ||||||
| Aortic stenosis | 51 (72.9) | 267 (75.2) | 0.822 | 51 (72.9) | 45 (64.3) | 0.754 |
| Aortic regurgitation | 12 (17.1) | 50 (14.1) | 0.502 | 12 (17.1) | 13 (18.6) | 0.825 |
| Combined | 7 (10.0) | 38 (10.7) | 0.763 | 7 (10.0) | 12 (17.1) | 0.217 |
| Etiology of the disease, | ||||||
| Senile degeneration | 53 (75.71) | 283 (80.4) | 0.350 | 53 (75.71) | 53 (75.71) | 1.000 |
| Annular expansion | 13 (18.6) | 47(13.4) | 0.238 | 13 (18.6) | 12 (17.14) | 0.825 |
| Mitral valve | 1 (1.4) | 0 (0.0) | 0.024 | 1 (1.4) | 0 (0.0) | 0.316 |
| Infective endocarditis | 3 (4.3) | 22 (6.3) | 0.538 | 3 (4.3) | 5 (7.14) | 0.466 |
| EuroSCORE II | ||||||
| <1%, | 24 (34.3) | 99 (27.8) | 0.253 | 24 (34.3) | 20 (28.6) | 0.466 |
| 1–3%, | 44 (62.9) | 201 (56.5) | 0.344 | 44 (62.9) | 42 (60.0) | 0.728 |
| >3%, | 2 (2.9) | 56 (15.7) | 0.004 | 2 (2.9) | 8 (11.4) | 0.049 |
| NYHA functional class, | ||||||
| II | 12 (17.14) | 41 (11.5) | 0.192 | 12 (17.14) | 6 (8.6) | 0.130 |
| III | 57 (81.43) | 301 (84.6) | 0.514 | 57 (81.43) | 64 (91.4) | 0.084 |
| IV | 1 (1.4) | 14 (3.9) | 0.299 | 1 (1.4) | 0 (0.0) | 0.316 |
| Creatinine clearance (mL/min) | ||||||
| <50, | 41 (58.6) | 3 (0.8) | 0.144 | 41 (58.6) | 36 (51.4) | 0.396 |
| 50–85, | 27 (38.6) | 196 (55.4) | 0.075 | 27 (38.6) | 31 (44.3) | 0.493 |
| >85, | 2 (2.86) | 155 (43.8) | 0.098 | 2 (2.86) | 3 (4.3) | 0.649 |
| Diabetes mellitus, | 11 (15.7) | 5 (7.1) | 0.111 | 11 (15.7) | 5 (7.1) | 0.111 |
| COPD, | 4 (5.7) | 0 (0.0) | 0.042 | 4 (5.7) | 0 (0.0) | 0.042 |
| Hypertension, | 22 (31.4) | 57 (16.1) | 0.003 | 22 (31.4) | 10 (16.0) | 0.016 |
| Stroke, | 0 (0.0) | 16 (4.5) | 0.086 | 0 (0.0) | 2 (2.9) | 0.154 |
| Coronary artery disease, | 3 (4.3) | 12 (3.4) | 0.723 | 3 (4.3) | 1 (1.4) | 0.310 |
| Renal failure, | 2 (2.9) | 1 (1.4) | 0.5590.000 | 2 (2.9) | 1 (1.4) | 0.559 |
| Pacemaker, | 5 (7.1) | 16 (4.5) | 1.000 | 5 (7.1) | 2 (2.9) | 0.245 |
| LVEF %, | ||||||
| <30% | 0 (0.0) | 0 (0.0) | ND | 0 (0.0) | 0 (0.0) | ND |
| 30–49% | 16 (22.9) | 11 (15.7) | 0.580 | 16 (22.9) | 11 (15.7) | 0.284 |
| ≥50% | 54 (77.1) | 59 (84.3) | 0.826 | 54 (77.1) | 59 (84.3) | 0.284 |
LVEF, left ventricular ejection fraction; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association Functional Classification; BMI, body mass index; EuroSCORE II, European System for Cardiac Operative Risk Evaluation, version II. ND, not determined.
Characteristics of surgery in the two groups.
| Indicator | Overall Cohort | Propensity Score Matched Cohort | ||||
|---|---|---|---|---|---|---|
| Full Sternotomy | Mini-Sternotomy |
| Full Sternotomy | Mini-Sternotomy |
| |
| Surgery duration, mean ± standard deviation (SD), min | 246.7 ± 74.2 | 263.5 ± 62.0 | 0.037 | 256.9 ± 79.7 | 263.5 ± 62.0 | 0.856 |
| Aortic cross-clamping time, mean ± SD, min | 79.9 ± 24.8 | 88.7 ± 20.7 | <0.001 | 80.3 ± 24.6 | 88.7 ± 20.7 | 0.007 |
| Cardiopulmonary bypass time, mean ± SD, min | 132.7 ± 44.5 | 144.0 ± 29.9 | 0.026 | 132.9 ± 44.9 | 144.0 ± 29.9 | 0.049 |
| Repeated cardioplegia, | 11 (3.1) | 0 (0.0) | 0.224 | 3(4.3) | 0 (0.0) | 0.080 |
| Valve type, | ||||||
| Biological | 163 (45.8) | 60 (85.7) | <0.001 | 24 (34.3) | 60 (85.7) | <0.001 |
| Mechanical | 193 (54.2) | 10 (14.3) | <0.001 | 46 (65.7) | 10 (14.3) | <0.001 |
| Size of aortic valve prosthesis, | ||||||
| 19 mm | 1 (0.3) | 0 (0.0) | 0.657 | 0 (0.0) | 0 (0.0) | ND |
| 21 mm | 57 (16.0) | 4 (5.6) | 0.025 | 7 (10.0) | 4 (5.7) | 0.346 |
| 23 mm | 154 (43.3) | 34 (47.2) | 0.549 | 36 (51.4) | 33 (47.1) | 0.612 |
| 25 mm | 111 (31.2) | 30 (41.7) | 0.095 | 19 (27.1) | 29 (41.4) | 0.075 |
| 27 mm | 31 (8.7) | 4 (5.6) | 0.404 | 8 (11.4) | 4 (5.7) | 0.227 |
| 29 mm | 2 (0.6) | 0 (0.0) | 0.530 | 0 (0.0) | 0 (0.0) | ND |
ND, not determined.
Postoperative outcomes.
| Indicator | Overall Cohort | Propensity Score Matched Cohort | ||||
|---|---|---|---|---|---|---|
| Full Sternotomy | Mini-Sternotomy |
| Full Sternotomy | Mini-Sternotomy |
| |
| Ventilation time, mean ± SD, h | 11.7 ± 17.0 | 9.7 ± 1.7 | 0.213 | 11.7 ± 1.4 | 9.7 ± 1.7 | <0.001 |
| Blood loss ≥1000 mL/24 h, | 27 (7.6) | 1 (1.4) | 0.069 | 2 (2.9) | 1 (1.4) | 0.559 |
| 24-h chest tube drainage, mean± SD, mL | 411.9 ± 294.6 | 256.2 ± 28.6 | <0.001 | 407.6 ± 40.37 | 256.2 ± 28.6 | <0.001 |
| Coagulopathy correction, | 87 (24.4) | 0 (0.0) | <0.001 | 14 (20.0) | 0 (0.0) | <0.001 |
| Blood product transfusion, | 78 (21.9) | 12 (17.1) | 0.265 | 15 (21.4) | 12 (17.1) | 0.520 |
| ICU stay, mean ± SD, h | 83.8 ± 124.8 | 68.97 ± 6.3 | 0.305 | 88.41 ± 20.62 | 68.97 ± 6.3 | 0.319 |
| Hospital stay, mean ± SD, days | 21.9 ± 18.2 | 18.3 ± 1.9 | 0.109 | 21.9 ± 1.9 | 18.3 ± 1.9 | 0.012 |
| Hospital stay after surgery, mean ± SD, days | 17.6 ± 16.9 | 13.06 ± 1.0 | 0.025 | 15.2 ± 1.5 | 13.06 ± 1.0 | 0.113 |
| 30-day mortality, | 13 (3.7) | 1 (1.4) | 0.022 | 0(0.0) | 1 (1.4) | 0.316 |
| Resternotomy, | 21 (6) | 0 (0.0) | <0.001 | 2(2.9) | 1 (1.4) | 0.559 |
| Endocarditis, | 18 (5.1) | 1 (1.4) | 0.384 | 5(7.1) | 1 (1.4) | 0.095 |
| Wound infection, | 19 (5.3) | 2 (2.9) | 0.645 | 2(2.9) | 2 (2.9) | 1,000 |
| Cardiac tamponade, | 15 (4.2) | 1 (1.4) | 0.489 | 1(1.4) | 1 (1.4) | 1.000 |
| Acute renal failure, | 28 (7.9) | 2 (2.9) | 0.067 | 1(1.4) | 2 (2.9) | 0.559 |
| Other actions, | 2 (0.6) | 1 (1.4) | 0.108 | 0 (0.0) | 1 (1.4) | 0.428 |
| Cardiac rhythm at discharge | 18 (5.1) | 3 (4.3) | 0.071 | 3 (4.3) | 3 (4.3) | 1.000 |
| Number of patients treated with: | 21 (30.0) | 4 (5.71) | <0.001 | 21(30.0) | 4 (5.71) | <0.001 |
| Morphine dose, mean ± SD, mg | 18.56 ± 17.08 | 8.33 ± 3.58 | <0.001 | 18.56 ± 17.08 | 8.33 ± 3.58 | <0.001 |
| LVEF% at discharge, | 7 (2.1) | 0 (0.0) | 0.732 | 0 (0.0) | 0 (0.0) | ND |
ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon pump; LVEF, left ventricular ejection fraction; ND, not determined.
Factors predicting mortality in patients undergoing aortic valve replacement.
| Variables | Relative Risk (RR) | 95% CI | |
|---|---|---|---|
| Preop hypertension (no vs. yes) | 1.717 | 0.320–9.209 | 0.528 |
| Preop LVEF (30–49% vs. >50%) | 0.156 | 0.031–0.774 | 0.023 |
| Aortotomy (transverse vs. J-shaped) | 0.761 | 0.124–4.668 | 0.768 |
| Type of cardioplegia | |||
| (coronary ostium vs. both) | 1.326 | 0.156–11.301 | 0.796 |
| (retrograde vs. both) | 0.140 | 0.006–3.494 | 0.231 |
| Aortic valve type (biological vs. mechanical) | 1.059 | 0.154–7.303 | 0.953 |
| Coagulopathy correction (no vs. yes) | 7.412 | 1.046–52.508 | 0.045 |
Figure 1Effect of surgery on post-surgery quality of life in the overall cohort (in the first 7 days after surgery). *** p < 0.001.
Figure 2Effect of surgery on post-surgery quality of life in the propensity matching cohort (in the first 7 days after surgery). *** p < 0.001.
Figure 3Survey into the cosmetic effects of both methods in the propensity matching cohort.
Figure 4Kaplan–Meier curves; 5-year survival curve of overall cohort.
Figure 5Kaplan–Meier curves; 5-year survival curve of propensity matching cohort.